|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Guidelines for the diagnosis and management of syncope (version 2009):the Task Force for the Diagnosis and management of Syncope of the European Society of Cardiology (ESC)显示文摘 | Moya A Sutton R Amm irati F | 2009 | Eur Heart J2009，30，： | 1 |
| 2 | Guidelines for the diagnosis and management of syncope (version 2009):the Task Force for the Diagnosis and management of Syncope of the European Society of Cardiology(ESC)显示文摘 | Moya A Sutton R Amm irati F | 2009 | Eur Heart J2009，30，： | 1 |
| 3 | Guidelines for the diagnosis and management of syncope (version 2009):the Task Force for the Diagnosis and management of Syncope of the European Society of Cardiology(ESC)显示文摘 | Moya A Sutton R Amm irati F | 2009 | Eur Heart J2009，30，： | 1 |
| 4 | Generation of nanocomposites based on (PMMA-b- PCL)-grafted Fe203 nanoparticles and PS-b-PCL block copolymer显示文摘 | Irati Barandiaran Ariel Cappelletti Miriam Strumia et al | 2014 | European Polymer Journal2014，58，： | 1 |
| 5 | A Marine Spatial Planning Approach to Select Suitable Areas for Installing Wave Energy Converters (WECs), on the Basque Continental Shelf (Bay of Biscay)显示文摘 | Ibon Galparsoro Pedro Liria Irati Legorburu Juan Bald Guillem Chust Pablo Ruiz-Minguela Germán Pérez Javier Marqués Yago Torre-Enciso Manuel González ángel Borja | 2012 | Coastal Management2012，，1： | 1 |
| 6 | Morphological characteristics of the Basque continental shelf(Bay of Biscay,northern Spain):their implications for integrated coastal zone management显示文摘 | Ibon G (A)ngel B Irati L | | 0，，： | 1 |
| 7 | Determination of gluten immunogenic peptides for the management of the treatment adherence of celiac disease: A systematic review显示文摘BACKGROUND Gluten is a complex mixture of proteins with immunogenic peptide sequences triggering the autoimmune activity in patients with celiac disease(CeD).Gluten immunogenic peptides(GIP)are resistant to gastrointestinal digestion and are then excreted via the stool and urine.Most common detection methods applied in the follow-up visits for CeD patients such as serology tests,dietetic interviews,questionnaires,and duodenal biopsy have been proved to be inefficient,invasive,or inaccurate for evaluating gluten-free diet(GFD)compliance.Determination of excreted GIP in stool and urine has been developed as a non-invasive,direct,and specific test for GFD monitoring.AIM To summarize published literature about the clinical utility of GIP determination in comparison to the tools employed for GFD monitoring.METHODS PubMed and Web of Science searches were performed using the keywords“gluten immunogenic peptides”or“gluten immunogenic peptide”and a combination of the previous terms with“feces”,“stools”,“urine”,“celiac disease”,“gluten-free diet”,and“adherence”to identify relevant clinical studies published in English and Spanish between 2012 to January 2021.Reference lists from the articles were reviewed to identify additional pertinent articles.Published articles and abstracts reporting the clinical use of GIP determination in stool and/or urine for the follow-up of patients with CeD in comparison with other tools in use were included.Case reports,commentaries,reviews,conference papers,letters,and publications that did not focus on the aims of this review were excluded.RESULTS Total of 15 publications were found that involved the use of GIP determination in stool and/or urine to monitor the adherence to the GFD in comparison to other tools.Studies included both children and adults diagnosed with CeD and healthy volunteers.Overall,these preliminary studies indicated that this novel technique was highly sensitive for the detection of GFD transgressions and therefore could facilitate the follow-up of patients with CeD.Tools identified in this work included the CeD-specific serology,dietetic questionnaires,symptomatology,and the duodenal biopsy.Review of the literature revealed that the rates of GFD adherence may vary between 30%-93%using either stool or urine GIP determination,49%-96%by the serology,59%-94%using the dietetic questionnaires,56%-95%by the reported symptoms and 44%-76%with the duodenal biopsy.In addition,the association between the different methods and histological abnormalities(Marsh II-III)was found to be 33%-100%for GIP determination(stool and urine),25%-39%for CeD-specific serology,3%-50%for dietetic questionnaires,and 22%-28%for the symptomatology.CONCLUSION Excreted GIP detection is the precise approach for determining voluntary or involuntary gluten consumption in CeD patients preventing future complications arising from gluten exposure. | Laura Coto Irati Mendia Carolina Sousa Julio César Bai Angel Cebolla | 2021 | World Journal of Gastroenterology2021，27，37： | 0 |
| 8 | 不同固定床位置生物质热解挥发物蒸汽催化重整反应中焦炭的形成和演化显示文摘对生物质热解挥发物蒸汽重整反应过程中催化剂的失活过程和主要机理进行了研究.在圆锥形喷动床反应器中于500℃进行生物质热解,随后在固定床反应器中于600℃进行重整反应;同时在不同轴向位置分析了催化剂位置对重整反应器的影响.采用N_(2)吸附-脱附、X射线衍射、扫描电镜、透射电镜、程序升温氧化、拉曼光谱和傅里叶变换红外光谱对失活样品进行表征.结果表明,焦炭沉积是初始催化剂活性衰减的主要原因,且没有观察到镍位点的烧结或氧化.随着反应的进行,沿着重整催化床观察到失活情况,焦炭沉积于催化剂内,其性质和组成取决于到达床中每个轴向位置的挥发物组成.在催化床的入口部分,焦炭沉积在Ni位点上,并且具有一定的含氧量.在更深的轴向床位置,催化剂与挥发性物质接触,该挥发性物质的组成已经明显改变,从而形成具有石墨化程度更高的焦炭,并且形成更多的缩合聚芳烃化合物.此外,沉积在所有失活样品上的焦炭没有呈现任何特定的形态,这也表明,无论所处的催化床位置和反应时间,焦炭均呈现无定形结构. | Enara Fernandez Laura Santamaria Irati García Maider Amutio Maite Artetxe Gartzen Lopez Javier Bilbao Martin Olazar | 2023 | Chinese Journal of Catalysis2023，48，5： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员